乳腺癌组织中Cyclin E及DNA倍性联合检测的临床意义
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY(2009)
Abstract
有研究认为DNA倍性异常与乳腺癌预后不良有关~([1-2]).Cyclin E是DNA复制过程中G0/G1期重要的细胞周期素,其过表达在细胞生长中的效应与细胞种类有关,可表现为生长抑制或促进增殖~([3]),是评估乳腺癌预后的一项重要指标~([4]).本研究联合检测CyclinE及DNA倍性,旨在为乳腺癌预后评估提供一较合理指标.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined